ADVFN Logo ADVFN

No pudimos encontrar ningún resultado para:
Asegúrate de que la ortografía sea correcta o intenta ampliar tu búsqueda.

Tendencias Ahora

Listas Principales

Parece que no has iniciado sesión.
Haz clic en el botón de abajo para iniciar sesión y ver tu historial reciente.

Hot Features

Registration Strip Icon for charts Regístrate para obtener gráficos en tiempo real, herramientas de análisis y precios.
XOMA Royalty Corporation

XOMA Royalty Corporation (XOMAO)

25.40
0.1529
(0.605542%)
Cerrado 27 Enero 3:00PM
25.40
0.00
(0.00%)
Fuera de horario: 2:59PM

Herramientas de nivel profesional para inversores individuales.

Estadísticas y detalles clave

Último Precio
25.40
Postura de Compra
25.27
Postura de Venta
25.41
Volume Operado de la Acción
918
25.25 Rango del Día 25.40
0.00 Rango de 52 semanas 0.00
Capitalización de Mercado [m]
Precio Anterior
25.25
Precio de Apertura
25.25
Última hora de negociación
Volumen financiero
US$ 23,320
Precio Promedio Ponderado
25.40
Volumen promedio (3 m)
-
Acciones en circulación
11,782,723
Rendimiento del Dividendo
8.24%
Ratio Precio/Utilidad
-7.79
Beneficio por acción (BPA)
-3.47
turnover
4.76M
Beneficio neto
-40.83M

Acerca de XOMA Royalty Corporation

XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnolo... XOMA Corp is a biotechnology royalty aggregator playing a unique role in helping biotech companies achieve their goal of improving human health. XOMA acquires the potential future economics associated with pre-commercial therapeutic candidates that have been licensed to pharmaceutical or biotechnology companies. When XOMA acquires future economic rights, the seller receives non-dilutive, non-recourse funding that can use to advance their internal drug candidate(s) or for general corporate purposes. Mostrar más

Sector
Pharmaceutical Preparations
Industria
Pharmaceutical Preparations
Sitio web
Sede
Wilmington, Delaware, USA
Fundado
-
XOMA Royalty Corporation is listed in the Pharmaceutical Preparations sector of the NASDAQ with ticker XOMAO. The last closing price for XOMA Royalty was US$25.25. Over the last year, XOMA Royalty shares have traded in a share price range of US$ 0.00 to US$ 0.00.

XOMA Royalty currently has 11,782,723 shares in issue. The market capitalisation of XOMA Royalty is US$297.51 million. XOMA Royalty has a price to earnings ratio (PE ratio) of -7.79.

XOMAO Últimas noticias

XOMA Royalty Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., Dec. 19, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of...

XOMA Royalty Acquires Pulmokine for $20 Million Adding the Royalty and Milestone Interest in Seralutinib, a Phase 3 Asset, to Its Portfolio

Seralutinib becomes XOMA Royalty’s seventh Phase 3 royalty asset, further building the late-stage pipeline beyond its six current commercial royalty assets Seralutinib is being developed and...

XOMA Royalty Reports Third Quarter 2024 Financial Results and Highlights Recent Activities

Zevra’s MIPLYFFA™ (arimoclomol) received FDA approval and became the sixth commercial asset in XOMA Royalty’s portfolio XOMA Royalty acquired a 50 percent economic interest in TWIST Bioscience’s...

XOMA Royalty Significantly Expands its Royalty and Milestone Portfolio with the Addition of Over 60 Early-Stage Programs from Twist Bioscience

XOMA Royalty has acquired 50 percent of Twist’s existing royalty and milestone economics for $15 million XOMA Royalty’s portfolio now holds over 100 assets ranging from revenue-generating...

Zevra’s MIPLYFFA™ (arimoclomol) Receives Approval from U.S. Food and Drug Administration for Use in Patients with Niemann-Pick Disease Type C (NPC)

MIPLYFFA™ is the first therapy approved for use in patients with NPC, a rare genetic disorder XOMA Royalty is entitled to receive a mid-single digit royalty on MIPLYFFA™ sales and up to $52.6...

XOMA Royalty Declares Quarterly Preferred Stock Dividends

 EMERYVILLE, Calif., Sept. 23, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following...

XOMA Royalty to Present at Upcoming Investor Conferences in September

EMERYVILLE, Calif., Sept. 04, 2024 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today members of its Executive Team will participate at...

XOMA Royalty Reports Second Quarter 2024 Financial Results and Highlights Recent Activities

Cash receipts totaled $22.6 million in 2Q24, inclusive of royalty income and milestones from Day One Pharmaceuticals and Rezolute Expanded the commercial royalty and milestone portfolio with the...

XOMA Declares Quarterly Preferred Stock Dividends

EMERYVILLE, Calif., June 20, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (Nasdaq: XOMA) (“XOMA” or the “Company”) today announced its Board of Directors has authorized the following cash dividends...

XOMA Receives $8.1 Million Milestone Related to Day One Biopharmaceuticals’ Sale of its Priority Review Voucher

EMERYVILLE, Calif., June 12, 2024 (GLOBE NEWSWIRE) -- XOMA Corporation (NASDAQ: XOMA), the biotech royalty aggregator, announced today it has received an $8.1 million milestone payment from...

Período †Variación(Ptos)Variación %AperturaPrecio MáximoPrecio MínimoAvg. Vol. diarioPrecio Promedio Ponderado
10000000PR
40000000PR
120000000PR
260000000PR
520000000PR
1560000000PR
2600000000PR

XOMAO - Preguntas Frecuentes

¿Cuál es el precio actual de las acciones de XOMA Royalty?
El precio actual de las acciones de XOMA Royalty es US$ 25.40
¿Cuántas acciones de XOMA Royalty están en circulación?
XOMA Royalty tiene 11,782,723 acciones en circulación
¿Cuál es la capitalización de mercado de XOMA Royalty?
La capitalización de mercado de XOMA Royalty es USD 297.51M
¿Cuál es el rango de negociación de 1 año para el precio de las acciones de XOMA Royalty?
XOMA Royalty ha negociado en un rango de US$ 0.00 a US$ 0.00 durante el último año
¿Cuál es el ratio PE (precio/beneficio) de XOMA Royalty?
El ratio precio/beneficio de XOMA Royalty es -7.79
¿Cuál es el ratio de efectivo a ventas de XOMA Royalty?
El ratio de efectivo a ventas de XOMA Royalty es 66.86
¿Cuál es la moneda de reporte de XOMA Royalty?
XOMA Royalty presenta sus resultados financieros en USD
¿Cuál es el último ingresos anual de XOMA Royalty?
El último ingresos anual de XOMA Royalty es USD 4.76M
¿Cuál es el último beneficio anual de XOMA Royalty?
El último beneficio anual de XOMA Royalty es USD -40.83M
¿Cuál es la dirección registrada de XOMA Royalty?
La dirección registrada de XOMA Royalty es CORPORATION TRUST CENTER, 1209 ORANGE ST, WILMINGTON, DELAWARE, 19801
¿Cuál es la dirección del sitio web de XOMA Royalty?
La dirección del sitio web de XOMA Royalty es www.xoma.com
¿En qué sector industrial opera XOMA Royalty?
XOMA Royalty opera en el sector PHARMACEUTICAL PREPARATIONS

Movimientos

Ver todo
  • Volumen
  • % Mayores Alzas
  • % Mayores Bajas
SímboloPrecioVol.
JGAurora Mobile Ltd
US$ 14.56
(142.18%)
38.51M
AKROAkero Therapeutics Inc
US$ 51.77
(97.75%)
15.06M
ORKTOrangeKloud Technology Inc
US$ 1.30
(88.41%)
62.83M
HWHHWH International Inc
US$ 0.49
(70.32%)
393.88M
GITSGlobal Interactive Technologies Inc
US$ 3.0424
(56.34%)
4.71M
ALLKAllakos Inc
US$ 0.2402
(-80.15%)
51.22M
NXUNXU Inc
US$ 0.2513
(-59.20%)
14.06M
VERUVeru Inc
US$ 0.6351
(-47.51%)
43.51M
WOKWORK Medical Technology Group Ltd
US$ 2.53
(-47.51%)
862.6k
NBISNebius Group NV
US$ 26.08
(-37.44%)
43.58M
NVDANVIDIA Corporation
US$ 118.42
(-16.97%)
798.94M
HWHHWH International Inc
US$ 0.49
(70.32%)
393.88M
HOLOMicroCloud Hologram Inc
US$ 1.67
(7.74%)
201.58M
ONCOOnconetix Inc
US$ 0.66
(37.50%)
185M
RGTIRigetti Computing Inc
US$ 12.44
(-5.76%)
123.5M
LTListener LTListener 4 minutos hace
That will be an interesting facet of re-engaging stakeholders as to how they anticipate re entering a liquid market for shares.

Many of us on this forum have speculated they may be spinning an asset out or looking at possible methods to merge to another exchange.
RSPI
Whalatane Whalatane 4 minutos hace
Copy. No large US corporations will use Chinese AI if some how some way the Chinese govt can back door into their data . Our govt is freaked out enough over data from kids on TikTok ......let alone from US corporations .
DeepSeek is Open Sourced ...so also in this space Meta , Apple etc wil
NVDA
cjstocksup cjstocksup 4 minutos hace
Where were the human rights for all the Americans murdered and sexually assaulted by her illegals?
https://truthsocial.com/@WallStreetApes/113902929612214702
glenn1919 glenn1919 4 minutos hace
MULN................................https://app.quotemedia.com/data/downloadFiling?type=HTML&webmasterId=501&ref=318866336
MULN
100lbStriper 100lbStriper 5 minutos hace
i just hope this is the final boc trial, ridiculous this is......
NLST
blackhawks blackhawks 5 minutos hace
Please, he has less charm than the guys he resembles; Goebbels or Roy Cohn.
crescentmotor crescentmotor 6 minutos hace
I hope they short another 10 million.

Yup--it really doesn't matter. AVXL, for the moment, is an all or nothing play--whether one is short or long the stock. But there are some current unknowns that may come into play providing potential additional challenges for the shorts. Those
AVXL
cjstocksup cjstocksup 6 minutos hace
A U.S. attorney reportedly has filed a motion to cancel an arrest warrant for a Jan. 6 defendant apprehended in Canada earlier this month. Read more: bit.ly/4jzS59v
https://truthsocial.com/@NewsMax/113902981698619333
Jiddy905 Jiddy905 7 minutos hace
What are you guys waiting on? New here.
CBDL
MartinLutherKing MartinLutherKing 7 minutos hace
AI-Powered Personalized mRna Vaccine In 48 Hours’: Trump’s $500B AI Plan Stargate Makes Big Claim
President Donald Trump has unveiled Stargate, a $500 billion AI-driven project by OpenAI, SoftBank, and Oracle, aimed at revolutionizing cancer treatment through early detection and personalized
RNAZ
1hunglo 1hunglo 8 minutos hace
I don’t call Korenko SLO-MO for nothing these past several years.
RDGL
JSmith5 JSmith5 8 minutos hace
Thanks Fully Diluted. Bessent handled himself very well in the Hearings. And I don't think anyone else is going to get such an overwhelmingly favorable vote.
Pulte will have a much harder time as I imagine they will be laser-focused on the fate of the GSEs. That's when we will get a lot m
FNMA
tombe tombe 8 minutos hace
https://fintel.io/ssv/us/eltp
ELTP
janice shell janice shell 9 minutos hace
This is a good anticipatory move by Australia:

https://x.com/politvidchannel/status/1883595751969935399?s=42
PennMilitia PennMilitia 9 minutos hace
Number one on-the-list-is complete - release by 2026
1. Scott Bessent confirmation - Confirmation complete.
2. Financial results
3. New FHFA director
4. Then all concerned parties will have the gag order lifted and will be able to discuss FNMA and FMCC exiting conservator
FMCC
Makw Makw 9 minutos hace
Not here to fight online . Hope it all works out for everyone . I don't day trade . I invest 
INKW
cjstocksup cjstocksup 9 minutos hace
This guy is a complete idiot!

NJ councilman Theodore Holloway from Gloucester County berates officer after being stopped for running a stop sign.

“You actually pulled over an elected official. You’re not pulling over a random. You’re pulling over your boss. I am literal
LTListener LTListener 10 minutos hace
Well this sounds positive. They appear to be planning on re-engaging the investment world!

And they should have a very nice story to tell with the progress of their candidates…. Sprinkle in some funding and/or partnerships and get some clinical trials rolling and there will be a co
RSPI
roadkilll roadkilll 10 minutos hace
Just speculating on the spike in volume and price. Maybe some of that sunshine Scott has been blowing is actually going to be actual news, soon.
ATOM
Jetmek_03052 Jetmek_03052 11 minutos hace
JEEZ. Take a pill.
DBMM
janice shell janice shell 11 minutos hace
I agree. Miller is still just over 40. He could last WAY too long.
MartinLutherKing MartinLutherKing 12 minutos hace
All hold hands and pray for news
RNAZ

Su Consulta Reciente

Delayed Upgrade Clock